The following components all participate in the DoD SBIR program, publishing solicitations exclusively for small businesses across multiple topic cycles per year: Department of Army (Army) Department of Navy (Navy) Department of Air Force (Air Force) Missile Defense Agency (MDA) Defense Advanced Research Projects Agency (DARPA) Defense Threat Reduction Agency (DTRA) Defense Health Agency (DHA) Special Operations Command (SOCOM) Defense Logistics Agency (DLA) Defense Microelectronics Agency (DMEA) Strategic Capabilities Office (SCO) Do all DoD agencies publish BAAs and OTAs in addition to SBIR
Who Benefits Most from Each Approach B12 Injections Prove Ideal For: Individuals with documented B12 deficiency requiring rapid correction achieve fastest results through injection therapy
Email Marketing: You may be asked to provide certain Personal Data, such as your name and email address, for the purpose of receiving email marketing communications
Products Pipeline BioChaperone Lispro in China: Positive Phase 3 results in people with type 1 and type 2 diabetes and marketing authorization filing under preparation The positive results of the two Phase 3 studies conducted by the partner, Tonghua Dongbao, of the ultra-rapid insulin BioChaperone Lispro in people with type 1 or type 2 diabetes in China were announced in July and October 2025 respectively
For example, research published in the Journal of Bodywork and Movement Therapies (2016) showed that myofascial release significantly reduced pain and improved function in patients with plantar fasciitis
The stack compounds that advantage by addressing the bottleneck that TRT alone doesn't fix: tissue durability under increased load